Cite
HARVARD Citation
Marton, C. et al. (n.d.). 40PInterest and potential of genetically engineered cord blood derived T cells for cancer immunotherapy. Annals of oncology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Marton, C. et al. (n.d.). 40PInterest and potential of genetically engineered cord blood derived T cells for cancer immunotherapy. Annals of oncology. p. . [Online].